Fundz

Access Bio, Inc. reported raising $10 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATENov 20, 2020

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Nov 20, 2020)

Round Type

Venture

SomersetBiotechnology

Quick answer

ACCESS BIO INC raised $10 Million in a funding round, dated November 20, 2020. ACCESS BIO INC is based in Somerset, New Jersey, United States.

How much did ACCESS BIO INC raise?
ACCESS BIO INC raised $10 Million in a funding round on November 20, 2020.
What does ACCESS BIO INC do?
Access BIO is a consulting group focused on the development of drug, biologic, and medical device products.
Where is ACCESS BIO INC based and how big is it?
ACCESS BIO INC is based in Somerset, New Jersey, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as ACCESS BIO INC that raised within 45 days of this round, from Fundz verified event records.

  • Juvenescence raised $2M (Seed) on January 4, 2021.
  • Cytovale raised $8M on January 4, 2021.
  • Color raised $127M on January 4, 2021.
  • Bio Green Med Solution, Inc. raised $7M on January 4, 2021.
  • Markman Biologics Corp raised an undisclosed amount on January 4, 2021.
  • CYTIMMUNE SCIENCES INC raised $998K (Seed) on December 31, 2020.

Who to call at ACCESS BIO INC, and when

A new round usually means ACCESS BIO INC is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ACCESS BIO INC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ACCESS BIO INC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ACCESS BIO INC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ACCESS BIO INC

Location

65 CLYDE ROAD

Somerset, New Jersey, United States

About

Access BIO is a consulting group focused on the development of drug, biologic, and medical device products.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ACCESS BIO INC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ACCESS BIO INC's next move

See what Strategic adds

ACCESS BIO INC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.